glp 1 agonist drug interactions Frontiers Glucagon-like peptide 1(GLP-1) receptor agonists
Description
Semaglutide mimics GLP-1 activity
Circulation 146(24):18821894 Mary P, Curtis R (2010) Weighing risks and benefits of liraglutide the FDAs review of a new antidiabetic therapy
Rarely, they may cause pancreatitis or gallbladder issues
"Today, fewer than 1 in 10 people who could benefit from a GLP-1 are taking one, held back by access, stigma, perceived complexity or the belief that their condition isn't serious enough for treatment
However, the results showed that in addition to the cardiovascular safety of GLP-1 receptor agonists, some drugs in the class can have influence on major adverse cardiovascular event (MACE) reduction compared to placebo (37)
Garca de Lucas MD, Olalla Sierra J, Pia Fernndez J
